Fate Therapeutics, Inc.
FATE
$1.08
$0.087.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 215.42M | 222.83M | 240.43M | 279.07M | 296.92M |
| Total Receivables | 2.08M | 3.40M | 4.41M | 5.64M | 6.03M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.75M | 4.17M | 3.39M | 7.20M | 7.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 221.25M | 230.40M | 248.22M | 291.91M | 310.29M |
|
|
|||||
| Total Current Assets | 221.25M | 230.40M | 248.22M | 291.91M | 310.29M |
| Net Property, Plant & Equipment | 101.89M | 104.91M | 107.94M | 110.89M | 140.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.23M | 10.23M | 10.23M | 10.24M | 10.24M |
| Total Assets | 343.67M | 371.63M | 398.67M | 440.69M | 494.97M |
|
|
|||||
| Total Accounts Payable | 3.50M | 4.04M | 4.19M | 9.37M | 6.35M |
| Total Accrued Expenses | 17.57M | 18.18M | 17.21M | 21.35M | 23.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.75M | 5.66M | 6.54M | 7.42M | 6.89M |
| Total Finance Division Other Current Liabilities | 2.29M | 795.00K | 212.00K | 393.00K | 600.00K |
| Total Other Current Liabilities | 2.29M | 795.00K | 212.00K | 393.00K | 600.00K |
| Total Current Liabilities | 28.11M | 28.67M | 28.16M | 38.52M | 37.42M |
|
|
|||||
| Total Current Liabilities | 28.11M | 28.67M | 28.16M | 38.52M | 37.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 74.49M | 75.68M | 76.79M | 77.85M | 92.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.00M | 5.92M | 5.32M | 5.60M | 3.14M |
| Total Liabilities | 109.61M | 110.27M | 110.26M | 121.97M | 132.64M |
|
|
|||||
| Common Stock & APIC | 1.74B | 1.73B | 1.72B | 1.72B | 1.71B |
| Retained Earnings | -1.50B | -1.47B | -1.44B | -1.40B | -1.35B |
| Treasury Stock & Other | 153.00K | 62.00K | 191.00K | 268.00K | 835.00K |
| Total Common Equity | 234.06M | 261.36M | 288.41M | 318.72M | 362.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 234.06M | 261.36M | 288.41M | 318.72M | 362.32M |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 234.07M | 261.36M | 288.41M | 318.73M | 362.33M |
|
|
|||||